ReviewIndian journal of pediatrics2024
Inflammatory Diseases of the Eye, Bowel, and Bone in Children.
Review in Indian journal of pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Inflammatory bowel disease in paediatric rheumatological diseases.Clinical rheumatology · 2025Article
- Pediatric Rheumatology: The Last Bastion of Pediatrics.Indian journal of pediatrics · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pediatric rheumatological diseases present with diverse manifestations affecting various tissues and organs. Though most childhood illnesses with immune dysregulation affect multiple organs or systems simultaneously or gradually, few inflammatory conditions affect certain organs as distinguished primary targets. Pediatric inflammatory diseases of the eye, bowel, and bone represent significant disorders with heterogeneous entities with varying pathophysiological basis like chronic inflammation, vasculitis, autoimmunity, and autoinflammation. Associations or complications of these diseases may remain obscure if their extensions are not explored specifically. Pediatric uveitis, non-uveitic inflammatory diseases, inflammatory bowel diseases, and autoinflammatory bone diseases are the important constituents of this cluster. The author concisely discusses these disorders in this review from pediatric rheumatological perspective. If untreated, these diseases may be organ-threatening. Outcomes are vastly different in undiagnosed patients and in timely diagnosed and treated patients. Lack of awareness and missed exploration of associated illnesses and complications may result in a missed diagnosis or inadequate symptomatic treatment. A multidisciplinary approach to diagnosis and treatment is desirable in these heterogeneous entities. Pediatricians must be aware of the immunological origin of organ-centered symptoms and signs. A proper understanding of molecular details of etiopathogenesis and significant advances in therapy have reduced the morbidity, disability, and mortality of such disorders.
Indexed as
Identifiers
37812374What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.